Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 1, 1999, Pages 346-348

  Sanyal, Saugato ^b   Smith, Peter R ^a   Saha, Animita C ^b   Gupta, Saswati ^b   Berkowitz, Leonard ^b   Homel, Peter ^b  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEFUROXIME; CLAVULANIC ACID; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MACROLIDE; TICARCILLIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COMMUNICABLE DISEASE; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; MORTALITY; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0012816946     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.1.9806048     Document Type: Article

References (11)

1. Garibaldi, R. A. 1985. Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology and impact. Am. J. Med. 78(Suppl. 6B):32S-37S.
2. U.S. Department of Commerce. 1984. Bureau of the Census Statistical Abstract of the United States (104th Edition), U.S. Government Printing Office, Washington, DC.
3. Reed, W. W., G. S. Byrd, R. H. Gates, Jr., R. S. Howard, and M. J. Weaver. 1996. Sputum Gram's slain in community-acquired pneumococcal pneumonia - a meta-analysis. West. J. Med. 165(4):197-204.
4. Mandell, L. A. 1995. Community acquired pneumonia: etiology, epidemiology and treatment. Chest 108:35S-42S.
5. Chalasani, N. P., M. I. Valdecans, A. K. Gopal, J. E. McGowan, Jr., and R. L. Jurado. 1995. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without underlying risks. Chest 108:932-936.
6. Bates, J. H., G. D. Campbell, A. L. Barron, G. A. McCravken, P. N. Morgan, E. B. Moses, and C. M. Davis. 1992. Microbial etiology of acute pneumonia in hospitalized patients. Chest 101:1005-1012.
7. Woodhead, M. A., J. Arrowsmith, R. Chamberlain-Webber, S. Wooding, and I. Williams. 1991. The value of routine microbial investigation in community-acquired pneumonia. Respir. Med. 85:313-317.
8. Niederman, M. S., J. B. Bass, G. D. Campbell, A. M. Fein, R. F. Grossman, L. A. Mandell, T. J. Marne, G. A. Sarosi, A. Torres, and V. L. Yu. 1993. Guidelines for the initial management of adults with community-acquired pneumonia, diagnosis, assessment of severity, and initial antimicrobial therapy. Am. Rev. Respir. Dis. 148:1418-1423.
9. Ewig, S., T. Bauer, E. Hasper, G. Marklein, I. R. Kubin, and B. Luderitz. 1996. Value of routine microbial investigation in community-acquired pneumonia treated in a tertiary care center. Respiration 63:164-169.
10. Pachon, J., M. D. Prados, F. Capote, J. A. Cuello, J. Garnacho, and A. Verono. 1990. Severe community-acquired pneumonia, etiology, prognosis and treatment. Am. Res. Respir. Dis. 142:369-373.
11. Moine, P., J.-B. Vercken, S. Chevret, C. Chastang, and P. Gajdos. 1994. Severe community-acquired pneumonia: etiology, epidemiology and prognosis factors. Chest 105:1487-1495.